ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Comorbidity in acute porphyria"
Episode Synopsis
It's a 2-for-1 podcast as Dr Mattias Lissing of the Karolinska Institute joins us to discuss two recent papers looking at cancer risk, comorbidity and mortality in the acute porphyrias.
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals
Mattias Lissing, et al
https://doi.org/10.1002/jimd.12583
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients
Mattias Lissing, et al
https://doi.org/10.1002/jimd.12676
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals
Mattias Lissing, et al
https://doi.org/10.1002/jimd.12583
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case–control study of 188 patients
Mattias Lissing, et al
https://doi.org/10.1002/jimd.12676
More episodes of the podcast JIMD Podcasts
Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants
30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff
23/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders
25/11/2025
IMD Research Round-Up: Mitochondrial disease
11/11/2025
In God we trust